A high frequency of peripheral blood NKG2D+NK and NKT cells in euthyroid patients with new onset hashimoto's thyroiditis-a pilot study

Immunological Investigations

Volumn 43, Issue 4, 2014, Pages 312-323

  Guo, Hui ^a   Xu, Bingchuan ^a   Yang, Xige ^a   Wang, Ye ^a   Liu, Xiaobo ^a   Cui, Chengri ^a   Jiang, Yanfang ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

CD107a; Hashimoto's thyroiditis; IFN ; NK cells; NKG2D; NKT cells

Indexed keywords

CD3 ANTIGEN; CD56 ANTIGEN; GAMMA INTERFERON; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR NKG2D; THYROID PEROXIDASE ANTIBODY; KLRK1 PROTEIN, HUMAN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K; NATURAL KILLER CELL RECEPTOR;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HASHIMOTO DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; MALE; NATURAL KILLER CELL; NATURAL KILLER T CELL; PILOT STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; BLOOD; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; METABOLISM; MIDDLE AGED;

ADULT; FEMALE; FLOW CYTOMETRY; HASHIMOTO DISEASE; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; NATURAL KILLER T-CELLS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; RECEPTORS, NATURAL KILLER CELL;

EID: 84897981296     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2013.854377     Document Type: Article

References (38)

1. Amino N, Mori H, Iwatani Y, et al. (1982). Peripheral K lymphocytes in autoimmune thyroid disease: decrease in Graves' disease and increase in Hashimoto's disease. J Clin Endocrinol Metab, 54, 587-91. (Pubitemid 13233810)
2. Bahram S, Inoko H, Shiina T, Radosavljevic M. (2005). MIC and other NKG2D ligands: from none to too many. Curr Opin Immunol, 17, 505-9. (Pubitemid 41207954)
3. Balashov KE, Khoury SJ, Hafler DA, Weiner HL. (1995). Inhibition of T cell responses by activated human CD8 Tcells is mediated by interferon-gamma and is defective in chronic progressive multiple sclerosis. J Clin Invest, 95, 2711-9.
4. Baxter AG, Smyth MJ. (2002). The role of NK cells in autoimmune disease. Autoimmunity, 35, 1-14. (Pubitemid 34678715)
5. Calder EA, Irvine WJ, Davidson NM, Wu FT. (1976). B and K cells in autoimmune thyroid disease. Clin Exp Immunol, 25, 17-23.
6. Carbone E, Neri P, Mesuraca M, et al. (2005). HLA class I, NKG2D and natu-ral cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells. Blood, 105, 251-8. (Pubitemid 40053090)
7. Coudert JD, Held W. (2006). The role of the NKG2D receptor for tumor immunity. Semin Cancer Biol, 16, 333-43. (Pubitemid 44311504)
8. del Prete GF, Maggi E, Mariotti S, et al. (1986). Cytolytic T lymphocytes with natural killer activity in thyroid infiltrate of patients with Hashimoto's thyroiditis: analysis at clonal level. J Clin Endocrinol Metab, 62, 52-7. (Pubitemid 16186842)
9. Doniach D. (1975). Humoral and genetic aspects of thyroid auto-immunity. J Clin Endocrinol Metab, 4, 267-85.
10. Fuertes MB, Girart MV, Molinero LL, et al. (2008). Intracellular retention of the NKG2D ligand MHC class I chain-related gene A in human melanomas confers immune privilege and prevents NK cell-mediated cytotoxicity. J Immunol, 180, 4606-14.
11. Ganesh BB, Bhattacharya P, Gopisetty A, Prabhakar BS. (2011). Role of cytokines in the pathogenesis and suppression of thyroid autoimmunity. J Interferon Cytokine Res, 31, 721-31.
12. Goto M, Tanimoto K, Chihara T, Horiuchi Y. (1981). Natural cell-mediated cytotoxicity in Sjogren's syndrome and rheumatoid arthritis. Arthritis Rheum, 24, 1377-82. (Pubitemid 12229389)
13. Hervier B, Beziat V, Haroche J, et al. (2011). Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-g production in patients with active disease. Arthritis Rheum, 63, 1698-706.
14. Hollowell JG, Staehling NW, Flanders WD, et al. (2002). Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab, 87, 489-99. (Pubitemid 34158210)
15. Lanier LL, Le AM, Civin CI, et al. (1986). The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol, 136, 4480-6. (Pubitemid 16090665)
16. Mariotti S, Caturegli P, Piccolo P, et al. (1990). Antithyroid peroxidase autoantibodies in thyroid diseases. J Clin Endocrinol Metab, 71, 661-9. (Pubitemid 20286067)
17. Martínez-Rodríguez JE, López-Botet M, Munteis E, et al. (2011). Natural killer cell phenotype and clinical response to interferon-beta therapy in multiple sclerosis. Clin Immunol, 141, 348-56.
18. Miyake S, Yamamura T. (2007). NKT cells and autoimmune diseases: unraveling the complexity. Curr Top Microbiol Immunol, 314, 251-67.
19. Papic M, Stein-Streilein J, Zakarija M, et al. (1987). Suppression of peripheral blood natural killer cell activity by excess thyroid hormone. J Clin Invest, 79, 404-8. (Pubitemid 17009672)
20. Park MJ, Bae JH, Chung JS, et al. (2011). Induction of NKG2D ligands and increased sensitivity of tumor cells to NK cell-mediated cytotoxicity by hematoporphyrin-based photodynamic therapy. Immunol Investig, 40, 367-82.
21. Pedersen BK, Feldt-Rasmussen U, Bech K, et al. (1989). Characterization of the natural killer activity in Hashimoto's and Graves' diseases. Allergy, 44, 477-81. (Pubitemid 19255793)
22. Pende D, Cantoni C, Rivera P, et al. (2001). Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recog-nizing tumors of nonepithelial origin. Eur J Immunol, 31, 1076-86.
23. Rodacki M, Svoren B, Butty V, et al. (2007). Altered natural killer cells in type 1 diabetic patients. Diabetes, 56, 177-85.
24. Roman-Gonzalez A, Moreno ME, Alfaro JM, et al. (2009). Frequency and function of circulating invariant NKT cells in autoimmune diabetes mellitus and thyroid diseases in Colombian patients. Hum Immunol, 70, 262-8.
25. Schade RO, Owen SG, Smart GA, Hall R. (1960). The relation of thyroid auto-immunity to round-celled infiltration of the thyroid gland. J Clin Pathol, 13, 499-501.
26. Schmidt RE, Murray C, Daley JF, et al. (1986). A subset of natural killer cells in peripheral blood displays a mature T cell phenotype. J Exp Med, 164, 351-6. (Pubitemid 16069248)
27. Schroder K, Hertzog PJ, Ravasi T, Hume DA. (2004). Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol, 75, 163-89. (Pubitemid 38174573)
28. Sivori S, Parolini S, Marcenaro E, et al. (2000). Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines. J Neuroimmunol, 107, 220-5. (Pubitemid 30347431)
29. Solerte SB, Precerutti S, Gazzaruso C, et al. (2005). Defect of a subpopulation of natural killer immune cells in Graves' disease and Hashimoto's thyroiditis: normalizing effect of dehydroepiandrosterone sulfate. Eur J Endocrinol, 152, 703-12. (Pubitemid 40744538)
30. Stassi G, De Maria R. (2002). Autoimmune thyroid disease: new models of cell death in autoimmunity. Nat Rev Immunol, 2, 195-204. (Pubitemid 37328766)
31. Strehl B, Seifert U, Krüger E, et al. (2005). Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing. Immunol Rev, 207, 19-30. (Pubitemid 41415005)
32. Verneris MR, Karami M, Baker J, et al. (2004). Role of NKG2D signaling in the cytotoxic-ity of activated and expanded CD8T cells. Blood, 103, 3065-72.
33. Vitti P, Rago T. (2003). Thyroid ultrasound as a predicator of thyroid disease. J Endocrinol Invest, 26, 686-9. (Pubitemid 37270704)
34. Wagtmann N, Rajagopalan S, Winter CC, et al. (1995). Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity, 3, 801-9. (Pubitemid 26092193)
35. Wakil AE, Wang ZE, Ryan JC, et al. (1998). Interferon gamma derived from CD4() T cells is sufficient to mediate T helper cell type 1 development. J Exp Med, 188, 1651-6. (Pubitemid 28516110)
36. Wenzel B, Chow A, Schleusener H, Wall JR. (1981). NK cell activity in autoimmune thyroid disorders. Proceedings of the 57th Annual Meeting of the American Thyroid Association. Minneapolis Abstract T26. Minneapolis, September 1981.
37. Yabuhara A, Yang FC, Nakazawa T, et al. (1996). A killing defect of natural killer cells as an underlying immunological abnormality in childhood systemic lupus erythema-tosus. J Rheumatol, 23, 171-7. (Pubitemid 26037216)
38. Yoshida H, Amino N, Yagawa K, et al. (1978). Association of serum antithyroid antibodies with lymphocytic infiltration of the thyroid gland: studies of seventy autopsied cases. J Clin Endocrinol Metab, 46, 859-62. (Pubitemid 8358346)